As the biologics landscape grows increasingly complex, CDMOs are under pressure to deliver more than additional manufacturing capacity. Emerging biotechs and established innovators alike are seeking partners capable of integrating development, anal... Read more
As pharmaceutical manufacturers face increasing pressure to maintain production continuity, ensure regulatory compliance, and manage ageing equipment, the traditional approach to spare parts management is being challenged. Long OEM lead times, compon... Read more
As drug development becomes increasingly complex, early-phase clinical trials are taking on a far more strategic role than simply establishing safety. Sponsors are now expected to generate meaningful evidence that informs dose selecti... Read more
The promise of precision oncology depends not only on scientific innovation but also on successful implementation in routine clinical practice. Drawing on real-world data from community oncology settings, Andrew Osterland, PharmD, MS, Research Scient... Read more
Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rate First tranche will fully refinance the existing New Money Facility, maturing in May 2027 Eliminates near‑term debt maturities and strengthens b... Read more
Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million Adjusted EBITA margin increased 40 basis points t... Read more
As the biopharmaceutical industry enters a new phase of growth, manufacturers are under increasing pressure to deliver greater capacity, accelerate innovation, and maintain the highest standards of quality and sustainability. Samsung Biologic... Read more
The biologics development landscape is becoming increasingly complex, requiring partners that offer more than manufacturing capacity alone. As biotech companies navigate tighter funding environments, accelerated development timelines, and growing sci... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
